{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T23:42:35Z","timestamp":1793922155413,"version":"4.8.0"},"reference-count":135,"publisher":"Elsevier BV","issue":"23","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,7]],"date-time":"2022-12-07T00:00:00Z","timestamp":1670371200000},"content-version":"vor","delay-in-days":371,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.jacc.2021.09.1367","type":"journal-article","created":{"date-parts":[[2021,11,29]],"date-time":"2021-11-29T15:01:56Z","timestamp":1638198116000},"page":"2354-2376","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":114,"title":["Evaluating Medical Therapy for Calcific Aortic Stenosis"],"prefix":"10.1016","volume":"78","author":[{"given":"Brian R.","family":"Lindman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devraj","family":"Sukul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc R.","family":"Dweck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahesh V.","family":"Madhavan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benoit J.","family":"Arsenault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"Coylewright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. David","family":"Merryman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David E.","family":"Newby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Frank E.","family":"Harrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Mack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin B.","family":"Leon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine M.","family":"Otto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Pibarot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2021.09.1367_bib1","doi-asserted-by":"crossref","first-page":"16006","DOI":"10.1038\/nrdp.2016.6","article-title":"Calcific aortic stenosis","volume":"2","author":"Lindman","year":"2016","journal-title":"Nat Rev Dis Primers"},{"issue":"11","key":"10.1016\/j.jacc.2021.09.1367_bib2","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.jacc.2013.05.015","article-title":"Aortic stenosis in the elderly: disease prevalence and number of candidates for transcatheter aortic valve replacement: a meta-analysis and modeling study","volume":"62","author":"Osnabrugge","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"25 Pt A","key":"10.1016\/j.jacc.2021.09.1367_bib3","doi-asserted-by":"crossref","first-page":"2852","DOI":"10.1016\/j.jacc.2014.04.018","article-title":"The prevalence, incidence, progression, and risks of aortic valve sclerosis: a systematic review and meta-analysis","volume":"63","author":"Coffey","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"47","key":"10.1016\/j.jacc.2021.09.1367_bib4","doi-asserted-by":"crossref","first-page":"3515","DOI":"10.1093\/eurheartj\/ehw229","article-title":"Large-scale community echocardiographic screening reveals a major burden of undiagnosed valvular heart disease in older people: the OxVALVE Population Cohort Study","volume":"37","author":"d'Arcy","year":"2016","journal-title":"Eur Heart J"},{"issue":"4","key":"10.1016\/j.jacc.2021.09.1367_bib5","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.1016\/j.jacc.2020.11.018","article-title":"2020 ACC\/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"77","author":"Otto","year":"2021","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"36","key":"10.1016\/j.jacc.2021.09.1367_bib6","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.1093\/eurheartj\/ehx391","article-title":"2017 ESC\/EACTS guidelines for the management of valvular heart disease","volume":"38","author":"Baumgartner","year":"2017","journal-title":"Eur Heart J"},{"issue":"25","key":"10.1016\/j.jacc.2021.09.1367_bib7","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1016\/j.jacc.2020.11.010","article-title":"GBD-NHLBI-JACC Global Burden of Cardiovascular Diseases Writing Group. Global burden of cardiovascular diseases and risk factors, 1990-2019: update from the GBD 2019 study","volume":"76","author":"Roth","year":"2020","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"26","key":"10.1016\/j.jacc.2021.09.1367_bib8","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1056\/NEJMsa1901109","article-title":"Procedural Volume and Outcomes for Transcatheter Aortic-Valve Replacement","volume":"380","author":"Vemulapalli","year":"2019","journal-title":"N\u00a0Engl J Med"},{"issue":"9","key":"10.1016\/j.jacc.2021.09.1367_bib9","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1001\/jamacardio.2021.2082","article-title":"Prevention and mitigation of heart failure in the treatment of calcific aortic stenosis: a unifying therapeutic principle","volume":"6","author":"Lindman","year":"2021","journal-title":"JAMA Cardiol"},{"issue":"2 Pt 1","key":"10.1016\/j.jacc.2021.09.1367_bib10","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.jcmg.2019.01.036","article-title":"Management of asymptomatic severe aortic stenosis: evolving concepts in timing of valve replacement","volume":"13","author":"Lindman","year":"2020","journal-title":"J\u00a0Am Coll Cardiol Img"},{"issue":"15","key":"10.1016\/j.jacc.2021.09.1367_bib11","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1161\/CIRCULATIONAHA.120.052531","article-title":"Unloading the stenotic path to identifying medical therapy for calcific aortic valve disease: barriers and opportunities","volume":"143","author":"Lindman","year":"2021","journal-title":"Circulation"},{"issue":"22","key":"10.1016\/j.jacc.2021.09.1367_bib12","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1161\/CIRCULATIONAHA.116.023997","article-title":"Medical treatment of aortic stenosis","volume":"134","author":"Marquis-Gravel","year":"2016","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.jacc.2021.09.1367_bib13","first-page":"1","article-title":"Pathophysiology of aortic stenosis and future perspectives for medical therapy","volume":"38","author":"Zheng","year":"2020","journal-title":"Cardiol Clin"},{"issue":"4","key":"10.1016\/j.jacc.2021.09.1367_bib14","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/nrcardio.2014.1","article-title":"Potential drug targets for calcific aortic valve disease","volume":"11","author":"Hutcheson","year":"2014","journal-title":"Nat Rev Cardiol"},{"issue":"24","key":"10.1016\/j.jacc.2021.09.1367_bib15","doi-asserted-by":"crossref","first-page":"3316","DOI":"10.1161\/CIRCULATIONAHA.104.486738","article-title":"Spectrum of calcific aortic valve disease: pathogenesis, disease progression, and treatment strategies","volume":"111","author":"Freeman","year":"2005","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.jacc.2021.09.1367_bib16","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1056\/NEJMra1313875","article-title":"Aortic-valve stenosis\u2014from patients at risk to severe valve obstruction","volume":"371","author":"Otto","year":"2014","journal-title":"N\u00a0Engl J Med"},{"issue":"10","key":"10.1016\/j.jacc.2021.09.1367_bib17","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCGEN.119.002617","article-title":"Genetic association analyses highlight IL6, ALPL, and NAV1 as 3 new susceptibility genes underlying calcific aortic valve stenosis","volume":"12","author":"Theriault","year":"2019","journal-title":"Circ Genom Precis Med"},{"issue":"1","key":"10.1016\/j.jacc.2021.09.1367_bib18","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1038\/s41467-018-03260-6","article-title":"A\u00a0transcriptome-wide association study identifies PALMD as a susceptibility gene for calcific aortic valve stenosis","volume":"9","author":"Theriault","year":"2018","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.jacc.2021.09.1367_bib19","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1038\/s41467-018-03252-6","article-title":"Genome-wide analysis yields new loci associating with aortic valve stenosis","volume":"9","author":"Helgadottir","year":"2018","journal-title":"Nat Commun"},{"issue":"8 Pt 1","key":"10.1016\/j.jacc.2021.09.1367_bib20","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1016\/j.jcmg.2019.02.034","article-title":"Multimodality imaging markers of adverse myocardial remodeling in aortic stenosis","volume":"12","author":"Treibel","year":"2019","journal-title":"J\u00a0Am Coll Cardiol Img"},{"issue":"2","key":"10.1016\/j.jacc.2021.09.1367_bib21","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1161\/CIRCULATIONAHA.109.900027","article-title":"Effect of lipid lowering with rosuvastatin on progression of aortic stenosis: results of the Aortic Stenosis Progression Observation: Measuring Effects of Rosuvastatin (ASTRONOMER) trial","volume":"121","author":"Chan","year":"2010","journal-title":"Circulation"},{"issue":"130","key":"10.1016\/j.jacc.2021.09.1367_bib22","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1056\/NEJMoa0804602","article-title":"Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis","volume":"359","author":"Rossebo","year":"2008","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.jacc.2021.09.1367_bib23","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1056\/NEJMoa1109034","article-title":"Genetic associations with valvular calcification and aortic stenosis","volume":"368","author":"Thanassoulis","year":"2013","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.jacc.2021.09.1367_bib24","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.cjco.2019.03.004","article-title":"Lipoprotein(a), oxidized phospholipids, and aortic valve microcalcification assessed by 18F-sodium fluoride positron emission tomography and computed tomography","volume":"1","author":"Despres","year":"2019","journal-title":"CJC Open"},{"issue":"17","key":"10.1016\/j.jacc.2021.09.1367_bib25","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1001\/jama.2014.13959","article-title":"CHARGE Extracoronary Calcium Working Group. Association of low-density lipoprotein cholesterol-related genetic variants with aortic valve calcium and incident aortic stenosis","volume":"312","author":"Smith","year":"2014","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.jacc.2021.09.1367_bib26","first-page":"649","article-title":"Genetic and in\u00a0vitro inhibition of PCSK9 and calcific aortic valve stenosis","volume":"5","author":"Perrot","year":"2020","journal-title":"J\u00a0Am Coll Cardiol Basic Transl Sci"},{"issue":"17","key":"10.1016\/j.jacc.2021.09.1367_bib27","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1016\/j.jacc.2019.01.070","article-title":"Lipoprotein(a) and oxidized phospholipids promote valve calcification in patients with aortic stenosis","volume":"73","author":"Zheng","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.jacc.2021.09.1367_bib28","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1056\/NEJMoa1905239","article-title":"AKCEA-APO(a)-LRx Study Investigators. Lipoprotein(a) reduction in persons with cardiovascular disease","volume":"382","author":"Tsimikas","year":"2020","journal-title":"N\u00a0Engl J Med"},{"issue":"16","key":"10.1016\/j.jacc.2021.09.1367_bib29","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1056\/NEJMoa1912387","article-title":"ORION-10 and ORION-11 Investigators. Two phase 3 trials of inclisiran in patients with elevated LDL cholesterol","volume":"382","author":"Ray","year":"2020","journal-title":"N\u00a0Engl J Med"},{"issue":"20","key":"10.1016\/j.jacc.2021.09.1367_bib30","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1161\/CIRCULATIONAHA.116.024270","article-title":"Dipeptidyl peptidase-4 induces aortic valve calcification by inhibiting insulin-like growth factor-1 signaling in valvular interstitial cells","volume":"135","author":"Choi","year":"2017","journal-title":"Circulation"},{"issue":"23","key":"10.1016\/j.jacc.2021.09.1367_bib31","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1136\/heartjnl-2020-317024","article-title":"Dipeptidyl peptidase-4 inhibition to prevent progression of calcific aortic stenosis","volume":"106","author":"Lee","year":"2020","journal-title":"Heart"},{"issue":"6","key":"10.1016\/j.jacc.2021.09.1367_bib32","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1007\/s00395-012-0306-0","article-title":"Pioglitazone attenuates progression of aortic valve calcification via down-regulating receptor for advanced glycation\u00a0end products","volume":"107","author":"Li","year":"2012","journal-title":"Basic Res Cardiol"},{"issue":"2","key":"10.1016\/j.jacc.2021.09.1367_bib33","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/nm1175","article-title":"Chronic inhibition of cyclic GMP phosphodiesterase 5A prevents and reverses cardiac hypertrophy","volume":"11","author":"Takimoto","year":"2005","journal-title":"Nat Med"},{"issue":"2","key":"10.1016\/j.jacc.2021.09.1367_bib34","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jacc.2008.08.069","article-title":"Sildenafil stops progressive chamber, cellular, and molecular remodeling and improves calcium handling and function in hearts with pre-existing advanced hypertrophy caused by pressure overload","volume":"53","author":"Nagayama","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"19","key":"10.1016\/j.jacc.2021.09.1367_bib35","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1161\/CIRCULATIONAHA.111.081125","article-title":"Effects of phosphodiesterase type 5 inhibition on systemic and pulmonary hemodynamics and ventricular function in patients with severe symptomatic aortic stenosis","volume":"125","author":"Lindman","year":"2012","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.jacc.2021.09.1367_bib36","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.jacc.2008.05.043","article-title":"Dysregulation of antioxidant mechanisms contributes to increased oxidative stress in calcific aortic valvular stenosis in humans","volume":"52","author":"Miller","year":"2008","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.jacc.2021.09.1367_bib37","doi-asserted-by":"crossref","first-page":"H1763","DOI":"10.1152\/ajpheart.51.2008","article-title":"Soluble guanylyl cyclase activation by HMR-1766 (ataciguat) in cells exposed to oxidative stress","volume":"295","author":"Zhou","year":"2008","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.jacc.2021.09.1367_bib38","doi-asserted-by":"crossref","first-page":"A123","DOI":"10.1161\/atvb.39.suppl_1.123","article-title":"Activation of oxidized soluble guanylate cyclase slows progression of aortic valve calcification","volume":"39","author":"Zhang","year":"2019","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"7056","key":"10.1016\/j.jacc.2021.09.1367_bib39","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/nature03940","article-title":"Mutations in NOTCH1 cause aortic valve disease","volume":"437","author":"Garg","year":"2005","journal-title":"Nature"},{"issue":"23","key":"10.1016\/j.jacc.2021.09.1367_bib40","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1161\/CIRCULATIONAHA.116.023116","article-title":"Altered DNA methylation of long noncoding RNA H19 in calcific aortic valve disease promotes mineralization by silencing NOTCH1","volume":"134","author":"Hadji","year":"2016","journal-title":"Circulation"},{"issue":"23","key":"10.1016\/j.jacc.2021.09.1367_bib41","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1161\/CIRCULATIONAHA.116.025601","article-title":"Lnc-ing NOTCH1 to idiopathic calcific aortic valve disease","volume":"134","author":"Merryman","year":"2016","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.jacc.2021.09.1367_bib42","first-page":"983","article-title":"Therapeutic inhibition of microRNA-34a ameliorates aortic valve calcification via modulation of Notch1-Runx2 signalling","volume":"116","author":"Toshima","year":"2020","journal-title":"Cardiovasc Res"},{"issue":"5","key":"10.1016\/j.jacc.2021.09.1367_bib43","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1093\/cvr\/cvz280","article-title":"Notch1 suppression by microRNA-34a: a new mechanism of calcific aortic valve disease","volume":"116","author":"Raddatz","year":"2020","journal-title":"Cardiovasc Res"},{"issue":"7","key":"10.1016\/j.jacc.2021.09.1367_bib44","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1161\/ATVBAHA.114.305095","article-title":"Notch1 mutation leads to valvular calcification through enhanced myofibroblast mechanotransduction","volume":"35","author":"Chen","year":"2015","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"10.1016\/j.jacc.2021.09.1367_bib45","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1161\/ATVBAHA.112.300278","article-title":"Cadherin-11 regulates cell-cell tension necessary for calcific nodule formation by valvular myofibroblasts","volume":"33","author":"Hutcheson","year":"2013","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"8","key":"10.1016\/j.jacc.2021.09.1367_bib46","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1161\/ATVBAHA.116.307812","article-title":"Cadherin-11 overexpression induces extracellular matrix remodeling and calcification in mature aortic valves","volume":"36","author":"Sung","year":"2016","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"24","key":"10.1016\/j.jacc.2021.09.1367_bib47","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1161\/CIRCULATIONAHA.117.027771","article-title":"Targeting Cadherin-11 prevents Notch1-mediated calcific aortic valve disease","volume":"135","author":"Clark","year":"2017","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.jacc.2021.09.1367_bib48","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.jacc.2015.05.066","article-title":"Calcification in aortic stenosis: the skeleton key","volume":"66","author":"Pawade","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"25","key":"10.1016\/j.jacc.2021.09.1367_bib49","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1161\/CIRCULATIONAHA.121.053708","article-title":"Effect of denosumab or alendronic acid on the progression of aortic stenosis: a double-blind randomized controlled trial","volume":"143","author":"Pawade","year":"2021","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.jacc.2021.09.1367_bib50","doi-asserted-by":"crossref","first-page":"386","DOI":"10.3390\/nu10040386","article-title":"Bicuspid aortic valve stenosis and the effect of vitamin K2 on calcification using (18)F-sodium fluoride positron emission tomography\/magnetic resonance: the BASIK2 rationale and trial design","volume":"10","author":"Peeters","year":"2018","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.jacc.2021.09.1367_bib51","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/s41467-019-14091-4","article-title":"Inhibition of vascular calcification by inositol phosphates derivatized with ethylene glycol oligomers","volume":"11","author":"Schantl","year":"2020","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.jacc.2021.09.1367_bib52","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1161\/HYPERTENSIONAHA.112.194878","article-title":"Hypertension in aortic stenosis: implications for left ventricular structure and cardiovascular events","volume":"60","author":"Rieck","year":"2012","journal-title":"Hypertension"},{"issue":"12","key":"10.1016\/j.jacc.2021.09.1367_bib53","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1111\/eci.12169","article-title":"Impact of hypertension and renin-angiotensin system inhibitors in aortic stenosis","volume":"43","author":"Capoulade","year":"2013","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.jacc.2021.09.1367_bib54","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.ijcard.2015.11.166","article-title":"Resting heart rate as a predictor of aortic valve stenosis progression","volume":"204","author":"de Oliveira Moraes","year":"2016","journal-title":"Int J Cardiol"},{"issue":"9","key":"10.1016\/j.jacc.2021.09.1367_bib55","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1161\/CIRCRESAHA.120.317979","article-title":"Multi-omics approaches to define calcific aortic valve disease pathogenesis","volume":"128","author":"Blaser","year":"2021","journal-title":"Circ Res"},{"key":"10.1016\/j.jacc.2021.09.1367_bib56","first-page":"388","article-title":"Identifying heart valve disease in primary care: differences between practice in Germany, France and the United Kingdom","volume":"3","author":"Webb","year":"2014","journal-title":"Eur J Cardiovasc Med"},{"issue":"9","key":"10.1016\/j.jacc.2021.09.1367_bib57","doi-asserted-by":"crossref","first-page":"5584","DOI":"10.21037\/jtd.2018.09.02","article-title":"Patient screening for early detection of aortic stenosis (AS)-review of current practice and future perspectives","volume":"10","author":"Thoenes","year":"2018","journal-title":"J\u00a0Thorac Dis"},{"issue":"7","key":"10.1016\/j.jacc.2021.09.1367_bib58","doi-asserted-by":"crossref","first-page":"883","DOI":"10.4244\/EIJY16M06_02","article-title":"Aortic valve stenosis: what do people know? A heart valve disease awareness survey of over 8,800 people aged 60 or over","volume":"12","author":"Gaede","year":"2016","journal-title":"EuroIntervention"},{"issue":"9","key":"10.1016\/j.jacc.2021.09.1367_bib59","article-title":"Priorities for patient-centered research in valvular heart disease: a report from the National Heart, Lung, and Blood Institute Working Group","volume":"9","author":"Lindman","year":"2020","journal-title":"J\u00a0Am Heart Assoc"},{"issue":"8","key":"10.1016\/j.jacc.2021.09.1367_bib60","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1111\/j.1365-2044.2009.05960.x","article-title":"Previously undiagnosed aortic stenosis revealed by auscultation in the hip fracture population\u2014echocardiographic findings, management and outcome","volume":"64","author":"McBrien","year":"2009","journal-title":"Anaesthesia"},{"issue":"22","key":"10.1016\/j.jacc.2021.09.1367_bib61","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1136\/heartjnl-2018-313082","article-title":"Cardiac auscultation poorly predicts the presence of valvular heart disease in asymptomatic primary care patients","volume":"104","author":"Gardezi","year":"2018","journal-title":"Heart"},{"issue":"3","key":"10.1016\/j.jacc.2021.09.1367_bib62","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/S0735-1097(96)00563-3","article-title":"Clinical factors associated with calcific aortic valve disease: Cardiovascular Health Study","volume":"29","author":"Stewart","year":"1997","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2021.09.1367_bib63","series-title":"The Population 65 Years and Older in the United States: 2016. American Community Survey Reports ACS-38","author":"Roberts","year":"2018"},{"issue":"12","key":"10.1016\/j.jacc.2021.09.1367_bib64","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1002\/clc.23499","article-title":"Point-of-care ultrasound: closing guideline gaps in screening for valvular heart disease","volume":"43","author":"Hammadah","year":"2020","journal-title":"Clin Cardiol"},{"issue":"7","key":"10.1016\/j.jacc.2021.09.1367_bib65","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.amjcard.2005.05.060","article-title":"Comparison of effectiveness of hand-carried ultrasound to bedside cardiovascular physical examination","volume":"96","author":"Kobal","year":"2005","journal-title":"Am J Cardiol"},{"issue":"4","key":"10.1016\/j.jacc.2021.09.1367_bib66","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1001\/jamacardio.2018.0001","article-title":"Time to add a fifth pillar to bedside physical examination: inspection, palpation, percussion, auscultation, and insonation","volume":"3","author":"Narula","year":"2018","journal-title":"JAMA Cardiol"},{"issue":"4","key":"10.1016\/j.jacc.2021.09.1367_bib67","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1136\/heartjnl-2018-313593","article-title":"Integration of echocardiographic screening by non-physicians with remote reading in primary care","volume":"105","author":"Nascimento","year":"2019","journal-title":"Heart"},{"issue":"3","key":"10.1016\/j.jacc.2021.09.1367_bib68","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1093\/ehjci\/jeaa263","article-title":"Prevalence and clinical implications of valvular calcification on coronary computed tomography angiography","volume":"22","author":"Williams","year":"2021","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"7","key":"10.1016\/j.jacc.2021.09.1367_bib69","article-title":"Deep learning-based algorithm for detecting aortic stenosis using electrocardiography","volume":"9","author":"Kwon","year":"2020","journal-title":"J\u00a0Am Heart Assoc"},{"issue":"3","key":"10.1016\/j.jacc.2021.09.1367_bib70","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/0735-1097(89)90590-1","article-title":"Hemodynamic progression of aortic stenosis in adults assessed by Doppler echocardiography","volume":"13","author":"Otto","year":"1989","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.jacc.2021.09.1367_bib71","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0002-9149(92)91280-H","article-title":"Rate of progression of valvular aortic stenosis in adults","volume":"70","author":"Faggiano","year":"1992","journal-title":"Am J Cardiol"},{"issue":"6","key":"10.1016\/j.jacc.2021.09.1367_bib72","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1378\/chest.103.6.1715","article-title":"Progression of aortic stenosis: role of age and concomitant coronary artery disease","volume":"103","author":"Peter","year":"1993","journal-title":"Chest"},{"issue":"9","key":"10.1016\/j.jacc.2021.09.1367_bib73","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1161\/01.CIR.95.9.2262","article-title":"Prospective study of asymptomatic valvular aortic stenosis: clinical, echocardiographic, and exercise predictors of outcome","volume":"95","author":"Otto","year":"1997","journal-title":"Circulation"},{"issue":"23","key":"10.1016\/j.jacc.2021.09.1367_bib74","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1056\/NEJMoa043876","article-title":"A\u00a0randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis","volume":"352","author":"Cowell","year":"2005","journal-title":"N\u00a0Engl J Med"},{"issue":"25","key":"10.1016\/j.jacc.2021.09.1367_bib75","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1093\/eurheartj\/ehs450","article-title":"Progression of aortic valve stenosis is associated with bone remodelling and secondary hyperparathyroidism in elderly patients\u2014the COFRASA study","volume":"34","author":"Hekimian","year":"2013","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.jacc.2021.09.1367_bib76","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jcmg.2014.09.016","article-title":"Impact of plasma Lp-PLA2 activity on the progression of aortic stenosis: the PROGRESSA study","volume":"8","author":"Capoulade","year":"2015","journal-title":"J\u00a0Am Coll Cardiol Img"},{"issue":"4","key":"10.1016\/j.jacc.2021.09.1367_bib77","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.jcmg.2016.02.006","article-title":"Sex differences in the progression of aortic stenosis and prognostic implication: the COFRASA-GENERAC study","volume":"9","author":"Nguyen","year":"2016","journal-title":"J\u00a0Am Coll Cardiol Img"},{"issue":"16","key":"10.1016\/j.jacc.2021.09.1367_bib78","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1016\/j.jacc.2017.02.037","article-title":"Impact of aortic valve calcification and sex on hemodynamic progression and clinical outcomes in AS","volume":"69","author":"Tastet","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.jacc.2021.09.1367_bib79","article-title":"ApoB\/ApoA-I ratio is associated with faster hemodynamic progression of aortic stenosis: results from the PROGRESSA (Metabolic Determinants of the Progression of Aortic Stenosis) study","volume":"7","author":"Tastet","year":"2018","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jacc.2021.09.1367_bib80","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ijcard.2018.03.070","article-title":"Impact of Fetuin-A on progression of calcific aortic valve stenosis: the COFRASA-GENERAC study","volume":"265","author":"Kubota","year":"2018","journal-title":"Int J Cardiol"},{"issue":"14","key":"10.1016\/j.jacc.2021.09.1367_bib81","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1016\/j.jacc.2019.01.043","article-title":"Oral anticoagulation therapy and progression of calcific aortic valve stenosis","volume":"73","author":"Tastet","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"24","key":"10.1016\/j.jacc.2021.09.1367_bib82","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1136\/heartjnl-2020-317125","article-title":"Computed tomography aortic valve calcium scoring for the assessment of aortic stenosis progression","volume":"106","author":"Doris","year":"2020","journal-title":"Heart"},{"issue":"14","key":"10.1016\/j.jacc.2021.09.1367_bib83","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1016\/j.jacc.2020.01.053","article-title":"Bone mineral density and progression rate of calcific aortic valve stenosis","volume":"75","author":"Tastet","year":"2020","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"7","key":"10.1016\/j.jacc.2021.09.1367_bib84","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1093\/ehjci\/jeaa068","article-title":"Effect of bicuspid aortic valve phenotype on progression of aortic stenosis","volume":"21","author":"Shen","year":"2020","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"2 Pt 1","key":"10.1016\/j.jacc.2021.09.1367_bib85","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0002-8703(05)80024-9","article-title":"Progression of aortic-stenosis in adults: new appraisal using Doppler echocardiography","volume":"119","author":"Roger","year":"1990","journal-title":"Am Heart J"},{"issue":"2","key":"10.1016\/j.jacc.2021.09.1367_bib86","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/0735-1097(94)00406-G","article-title":"Progression of aortic stenosis in 394 patients: relation to changes in myocardial and mitral valve dysfunction","volume":"25","author":"Brener","year":"1995","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"9","key":"10.1016\/j.jacc.2021.09.1367_bib87","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/S0002-9149(99)00496-8","article-title":"Factors leading to progression of valvular aortic stenosis","volume":"84","author":"Bahler","year":"1999","journal-title":"Am J Cardiol"},{"issue":"21","key":"10.1016\/j.jacc.2021.09.1367_bib88","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1161\/01.CIR.101.21.2497","article-title":"New insights into the progression of aortic stenosis: implications for secondary prevention","volume":"101","author":"Palta","year":"2000","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.jacc.2021.09.1367_bib89","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.ehj.2003.12.002","article-title":"Mild and moderate aortic stenosis: natural history and risk stratification by echocardiography","volume":"25","author":"Rosenhek","year":"2004","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.jacc.2021.09.1367_bib90","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.amjcard.2014.09.049","article-title":"Predictors and progression of aortic stenosis in patients with preserved left ventricular ejection fraction","volume":"115","author":"Ersboll","year":"2015","journal-title":"Am J Cardiol"},{"issue":"8","key":"10.1016\/j.jacc.2021.09.1367_bib91","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1253\/circj.CJ-16-0333","article-title":"Predictors of rapid progression and clinical outcome of asymptomatic severe aortic stenosis","volume":"80","author":"Nishimura","year":"2016","journal-title":"Circ J"},{"issue":"7","key":"10.1016\/j.jacc.2021.09.1367_bib92","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1093\/ehjci\/jeaa075","article-title":"Progression of aortic stenosis and echocardiographic criteria for its severity","volume":"21","author":"Kebed","year":"2020","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.jacc.2021.09.1367_bib93","first-page":"100592","article-title":"Initial changes in peak aortic jet velocity and mean gradient predict progression to severe aortic stenosis","volume":"30","author":"Nayeri","year":"2020","journal-title":"Int J Cardiol Heart Vasc"},{"issue":"1","key":"10.1016\/j.jacc.2021.09.1367_bib94","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1093\/ehjci\/jew013","article-title":"Systolic hypertension and progression of aortic valve calcification in patients with aortic stenosis: results from the PROGRESSA study","volume":"18","author":"Tastet","year":"2017","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"10","key":"10.1016\/j.jacc.2021.09.1367_bib95","article-title":"Age, sex, and valve phenotype differences in fibro-calcific remodeling of calcified aortic valve","volume":"9","author":"Voisine","year":"2020","journal-title":"J\u00a0Am Heart Assoc"},{"issue":"8","key":"10.1016\/j.jacc.2021.09.1367_bib96","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1093\/eurheartj\/ehv560","article-title":"Sex-related differences in calcific aortic stenosis: correlating clinical and echocardiographic characteristics and computed tomography aortic valve calcium score to excised aortic valve weight","volume":"37","author":"Thaden","year":"2016","journal-title":"Eur Heart J"},{"issue":"4","key":"10.1016\/j.jacc.2021.09.1367_bib97","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1161\/CIRCRESAHA.116.309306","article-title":"Sex-related discordance between aortic valve calcification and hemodynamic severity of aortic stenosis: is valvular fibrosis the explanation?","volume":"120","author":"Simard","year":"2017","journal-title":"Circ Res"},{"issue":"6","key":"10.1016\/j.jacc.2021.09.1367_bib98","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/j.jcmg.2021.01.017","article-title":"Aortic stenosis progression, cardiac damage, and survival: comparison between bicuspid and tricuspid aortic valves","volume":"14","author":"Yang","year":"2021","journal-title":"J\u00a0Am Coll Cardiol Img"},{"issue":"12","key":"10.1016\/j.jacc.2021.09.1367_bib99","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/j.jacc.2014.05.066","article-title":"Impact of aortic valve calcification, as measured by MDCT, on survival in patients with aortic stenosis: results of an international registry study","volume":"64","author":"Clavel","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.jacc.2021.09.1367_bib100","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.117.007146","article-title":"Computed tomography aortic valve calcium scoring in patients with aortic stenosis","volume":"11","author":"Pawade","year":"2018","journal-title":"Circ Cardiovasc Imaging"},{"issue":"4","key":"10.1016\/j.jacc.2021.09.1367_bib101","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1007\/s12350-017-1158-7","article-title":"Molecular imaging of calcific aortic valve disease","volume":"25","author":"Jung","year":"2018","journal-title":"J\u00a0Nucl Cardiol"},{"issue":"2","key":"10.1016\/j.jacc.2021.09.1367_bib102","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1161\/CIRCIMAGING.113.001508","article-title":"18F-sodium fluoride uptake is a marker of active calcification and disease progression in patients with aortic stenosis","volume":"7","author":"Dweck","year":"2014","journal-title":"Circ Cardiovasc Imaging"},{"issue":"1","key":"10.1016\/j.jacc.2021.09.1367_bib103","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1161\/CIRCULATIONAHA.111.051052","article-title":"Assessment of valvular calcification and inflammation by positron emission tomography in patients with aortic stenosis","volume":"125","author":"Dweck","year":"2012","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.jacc.2021.09.1367_bib104","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.jacc.2012.03.052","article-title":"Impact of metabolic syndrome on progression of aortic stenosis: influence of age and statin therapy","volume":"60","author":"Capoulade","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"11","key":"10.1016\/j.jacc.2021.09.1367_bib105","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1016\/j.jacc.2015.07.020","article-title":"Oxidized phospholipids, lipoprotein(a), and progression of calcific aortic valve stenosis","volume":"66","author":"Capoulade","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"8","key":"10.1016\/j.jacc.2021.09.1367_bib106","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1001\/jamacardio.2019.2202","article-title":"Systolic blood pressure and risk of valvular heart disease: a Mendelian randomization study","volume":"4","author":"Nazarzadeh","year":"2019","journal-title":"JAMA Cardiol"},{"issue":"40","key":"10.1016\/j.jacc.2021.09.1367_bib107","doi-asserted-by":"crossref","first-page":"3913","DOI":"10.1093\/eurheartj\/ehaa070","article-title":"Plasma lipids and risk of aortic valve stenosis: a Mendelian randomization study","volume":"41","author":"Nazarzadeh","year":"2020","journal-title":"Eur Heart J"},{"issue":"9","key":"10.1016\/j.jacc.2021.09.1367_bib108","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1016\/j.jcmg.2021.03.020","article-title":"Artificial Intelligence for Aortic Stenosis at Risk International Consortium. A machine-learning framework to identify distinct phenotypes of aortic stenosis severity","volume":"14","author":"Sengupta","year":"2021","journal-title":"J\u00a0Am Coll Cardiol Img"},{"issue":"3","key":"10.1016\/j.jacc.2021.09.1367_bib109","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.jacc.2020.11.030","article-title":"Machine learning and the future of cardiovascular care: JACC State-of-the-Art Review","volume":"77","author":"Quer","year":"2021","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"9","key":"10.1016\/j.jacc.2021.09.1367_bib110","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-014327","article-title":"Patient values and preferences on transcatheter or surgical aortic valve replacement therapy for aortic stenosis: a systematic review","volume":"6","author":"Lytvyn","year":"2016","journal-title":"BMJ Open"},{"issue":"2","key":"10.1016\/j.jacc.2021.09.1367_bib111","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1177\/2168479017716715","article-title":"Assessing the financial value of patient engagement: a quantitative approach from CTTI's Patient Groups and Clinical Trials Project","volume":"52","author":"Levitan","year":"2018","journal-title":"Ther Innov Regul Sci"},{"issue":"suppl 6","key":"10.1016\/j.jacc.2021.09.1367_bib112","doi-asserted-by":"crossref","first-page":"S66","DOI":"10.1097\/MLR.0000000000001264","article-title":"Network engagement in action: stakeholder engagement activities to enhance patient-centeredness of research","volume":"58","author":"Poger","year":"2020","journal-title":"Med Care"},{"key":"10.1016\/j.jacc.2021.09.1367_bib113","series-title":"Patient Preference Information \u2013 Voluntary Submission, Review in Premarket Approval Applications, Humanitarian Device Exemption Applications, and De Novo Requests, and Inclusion in Decision Summaries and Device Labeling","year":"2016"},{"issue":"9","key":"10.1016\/j.jacc.2021.09.1367_bib114","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.amjmed.2011.12.013","article-title":"Adherence to drugs that prevent cardiovascular disease: meta-analysis on 376,162 patients","volume":"125","author":"Naderi","year":"2012","journal-title":"Am J Med"},{"issue":"3","key":"10.1016\/j.jacc.2021.09.1367_bib115","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1056\/NEJMoa2028220","article-title":"Polypill with or without aspirin in persons without cardiovascular disease","volume":"384","author":"Yusuf","year":"2021","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.jacc.2021.09.1367_bib116","doi-asserted-by":"crossref","first-page":"70.e9","DOI":"10.1016\/j.amjmed.2005.08.019","article-title":"Racial differences in blood pressure control: potential explanatory factors","volume":"119","author":"Bosworth","year":"2006","journal-title":"Am J Med"},{"issue":"1","key":"10.1016\/j.jacc.2021.09.1367_bib117","first-page":"17","article-title":"Racial differences in adherence to cardiac medications","volume":"95","author":"Charles","year":"2003","journal-title":"J\u00a0Natl Med Assoc"},{"key":"10.1016\/j.jacc.2021.09.1367_bib118","doi-asserted-by":"crossref","DOI":"10.1007\/s11239-021-02432-4","article-title":"Relationship of health literacy and adherence to oral anticoagulation therapy in patients with atrial fibrillation: a cross-sectional study","author":"Bartolazzi","year":"2021","journal-title":"J\u00a0Thromb Thrombolysis"},{"issue":"8","key":"10.1016\/j.jacc.2021.09.1367_bib119","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1093\/europace\/euv421","article-title":"Real-world persistence and adherence to oral anticoagulation for stroke risk reduction in patients with atrial fibrillation","volume":"18","author":"Beyer-Westendorf","year":"2016","journal-title":"Europace"},{"issue":"1","key":"10.1016\/j.jacc.2021.09.1367_bib120","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s12872-021-01901-1","article-title":"Natural history observations in moderate aortic stenosis","volume":"21","author":"Du","year":"2021","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.jacc.2021.09.1367_bib121","series-title":"General COVID-19 therapeutics trial design","author":"Harrell","year":"2021"},{"issue":"4","key":"10.1016\/j.jacc.2021.09.1367_bib122","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.echo.2017.02.009","article-title":"Recommendations on the echocardiographic assessment of aortic valve stenosis: a focused update from the European Association of Cardiovascular Imaging and the American Society of Echocardiography","volume":"30","author":"Baumgartner","year":"2017","journal-title":"J\u00a0Am Soc Echocardiogr"},{"key":"10.1016\/j.jacc.2021.09.1367_bib123","doi-asserted-by":"crossref","DOI":"10.1136\/heartjnl-2020-318556","article-title":"Contrast-enhanced computed tomography assessment of aortic stenosis","author":"Cartlidge","year":"2021","journal-title":"Heart"},{"issue":"9","key":"10.1016\/j.jacc.2021.09.1367_bib124","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1016\/j.jcmg.2019.01.045","article-title":"Why and how to measure aortic valve calcification in patients with aortic stenosis","volume":"12","author":"Pawade","year":"2019","journal-title":"J\u00a0Am Coll Cardiol Img"},{"key":"10.1016\/j.jacc.2021.09.1367_bib125","series-title":"Drugs for Human Use Part 314 Applications for FDA Approval to Market a New Drug Subpart H Accelerated Approval of New Drugs for Serious or Life-Threatening Illnesses","year":"2020"},{"issue":"21","key":"10.1016\/j.jacc.2021.09.1367_bib129","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1161\/CIRCULATIONAHA.119.041728","article-title":"Overcoming lack of diversity in cardiovascular clinical trials: a new challenge and strategies for success","volume":"140","author":"Ortega","year":"2019","journal-title":"Circulation"},{"issue":"15","key":"10.1016\/j.jacc.2021.09.1367_bib130","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1001\/archinte.162.15.1682","article-title":"Representation of the elderly, women, and minorities in heart failure clinical trials","volume":"162","author":"Heiat","year":"2002","journal-title":"Arch Intern Med"},{"issue":"16","key":"10.1016\/j.jacc.2021.09.1367_bib131","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1001\/jama.2015.2316","article-title":"The platform trial: an efficient strategy for evaluating multiple treatments","volume":"313","author":"Berry","year":"2015","journal-title":"JAMA"},{"issue":"10289","key":"10.1016\/j.jacc.2021.09.1367_bib132","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1016\/S0140-6736(21)00897-7","article-title":"Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial","volume":"397","year":"2021","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.jacc.2021.09.1367_bib133","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/s41573-019-0034-3","article-title":"Adaptive Platform Trials Coalition. Adaptive platform trials: definition, design, conduct and reporting considerations","volume":"18","year":"2019","journal-title":"Nat Rev Drug Discov"},{"issue":"3","key":"10.1016\/j.jacc.2021.09.1367_bib134","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1177\/1740774515626362","article-title":"Efficiencies of platform clinical trials: a vision of the future","volume":"13","author":"Saville","year":"2016","journal-title":"Clin Trials"},{"issue":"25","key":"10.1016\/j.jacc.2021.09.1367_bib135","doi-asserted-by":"crossref","first-page":"2955","DOI":"10.1002\/sim.5404","article-title":"Bayesian clinical trials in action","volume":"31","author":"Lee","year":"2012","journal-title":"Stat Med"},{"key":"10.1016\/j.jacc.2021.09.1367_bib136","series-title":"Adaptive Designs for Clinical Trials of Drugs and Biologics Guidance","year":"2019"},{"issue":"1","key":"10.1016\/j.jacc.2021.09.1367_bib137","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/clpt.2009.68","article-title":"I-SPY 2: an adaptive breast cancer trial design in the setting of neoadjuvant chemotherapy","volume":"86","author":"Barker","year":"2009","journal-title":"Clin Pharmacol Ther"},{"issue":"7","key":"10.1016\/j.jacc.2021.09.1367_bib138","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1513\/AnnalsATS.202003-192SD","article-title":"The REMAP-CAP (Randomized Embedded Multifactorial Adaptive Platform for Community-acquired Pneumonia) study: rationale and Design","volume":"17","author":"Angus","year":"2020","journal-title":"Ann Am Thorac Soc"}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109721077445?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109721077445?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T13:47:08Z","timestamp":1760017628000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109721077445"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":135,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["S0735109721077445"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2021.09.1367","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluating Medical Therapy for Calcific Aortic Stenosis","name":"articletitle","label":"Article Title"},{"value":"Journal of the American College of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2021.09.1367","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}